Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies

PURPOSE OF REVIEW: Immunotherapies have demonstrated robust clinical efficacy in treating malignancies with increasing use and FDA approvals. We review the epidemiology, risk factors, diagnosis, and treatment of immunotherapy-associated cardiovascular toxicities. RECENT FINDINGS: Cardiotoxicity is r...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein-Merlob, Ashley F., Rothberg, Michael V., Holman, Patrick, Yang, Eric H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Cardio-Oncology (TG Neilan, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821837/
https://www.ncbi.nlm.nih.gov/pubmed/33483873
http://dx.doi.org/10.1007/s11886-021-01440-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821837/
https://www.ncbi.nlm.nih.gov/pubmed/33483873
http://dx.doi.org/10.1007/s11886-021-01440-3

Ejemplares similares